Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Cash from Investing Activities (2016 - 2025)

Bio Key International's Cash from Investing Activities history spans 15 years, with the latest figure at -$1325.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 93.74% year-over-year to -$1325.0; the TTM value through Sep 2025 reached $2627.0, up 110.92%, while the annual FY2024 figure was -$13047.0, 1204.7% down from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$1325.0 at Bio Key International, up from -$1478.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $10000.0 in Q4 2024 and bottomed at -$545037.0 in Q1 2022.
  • The 5-year median for Cash from Investing Activities is -$4570.0 (2025), against an average of -$50670.8.
  • The largest annual shift saw Cash from Investing Activities plummeted 3995.87% in 2022 before it skyrocketed 1100.0% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$4141.0 in 2021, then crashed by 3062.86% to -$130974.0 in 2022, then skyrocketed by 99.24% to -$1000.0 in 2023, then surged by 1100.0% to $10000.0 in 2024, then plummeted by 113.25% to -$1325.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Cash from Investing Activities are -$1325.0 (Q3 2025), -$1478.0 (Q2 2025), and -$4570.0 (Q1 2025).